205 related articles for article (PubMed ID: 32966755)
21. Cough in Patients With Lung Cancer: A Longitudinal Observational Study of Characterization and Clinical Associations.
Harle ASM; Blackhall FH; Molassiotis A; Yorke J; Dockry R; Holt KJ; Yuill D; Baker K; Smith JA
Chest; 2019 Jan; 155(1):103-113. PubMed ID: 30321508
[TBL] [Abstract][Full Text] [Related]
22. A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.
Birring SS; Wijsenbeek MS; Agrawal S; van den Berg JWK; Stone H; Maher TM; Tutuncu A; Morice AH
Lancet Respir Med; 2017 Oct; 5(10):806-815. PubMed ID: 28923239
[TBL] [Abstract][Full Text] [Related]
23. Aprepitant in Anti-histamine-refractory Chronic Nodular Prurigo: A Multicentre, Randomized, Double-blind, Placebo-controlled, Cross-over, Phase-II trial (APREPRU).
Tsianakas A; Zeidler C; Riepe C; Borowski M; Forner C; Gerss J; Metz M; Staubach P; Raap U; Kaatz M; Urban M; Luger TA; Ständer S
Acta Derm Venereol; 2019 Apr; 99(4):379-385. PubMed ID: 30653242
[TBL] [Abstract][Full Text] [Related]
24. Targeting fatty acid amide hydrolase as a therapeutic strategy for antitussive therapy.
Wortley MA; Adcock JJ; Dubuis ED; Maher SA; Bonvini SJ; Delescluse I; Kinloch R; McMurray G; Perros-Huguet C; Papakosta M; Birrell MA; Belvisi MG
Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28931663
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind, placebo-controlled, phase III cross-over study evaluating the oral neurokinin-1 antagonist aprepitant in combination with a 5HT3 receptor antagonist and dexamethasone in patients with germ cell tumors receiving 5-day cisplatin combination chemotherapy regimens: a hoosier oncology group study.
Albany C; Brames MJ; Fausel C; Johnson CS; Picus J; Einhorn LH
J Clin Oncol; 2012 Nov; 30(32):3998-4003. PubMed ID: 22915652
[TBL] [Abstract][Full Text] [Related]
26. Aprepitant as an add-on therapy in children receiving highly emetogenic chemotherapy: a randomized, double-blind, placebo-controlled trial.
Bakhshi S; Batra A; Biswas B; Dhawan D; Paul R; Sreenivas V
Support Care Cancer; 2015 Nov; 23(11):3229-37. PubMed ID: 25851802
[TBL] [Abstract][Full Text] [Related]
27. The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
Hesketh PJ; Grunberg SM; Gralla RJ; Warr DG; Roila F; de Wit R; Chawla SP; Carides AD; Ianus J; Elmer ME; Evans JK; Beck K; Reines S; Horgan KJ;
J Clin Oncol; 2003 Nov; 21(22):4112-9. PubMed ID: 14559886
[TBL] [Abstract][Full Text] [Related]
28. Theobromine inhibits sensory nerve activation and cough.
Usmani OS; Belvisi MG; Patel HJ; Crispino N; Birrell MA; Korbonits M; Korbonits D; Barnes PJ
FASEB J; 2005 Feb; 19(2):231-3. PubMed ID: 15548587
[TBL] [Abstract][Full Text] [Related]
29. Randomized, double-blind, placebo-controlled study of aprepitant versus two dosages of olanzapine with ondansetron plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving high-emetogenic chemotherapy.
Ithimakin S; Theeratrakul P; Laocharoenkiat A; Nimmannit A; Akewanlop C; Soparattanapaisarn N; Techawattanawanna S; Korphaisarn K; Danchaivijitr P
Support Care Cancer; 2020 Nov; 28(11):5335-5342. PubMed ID: 32128615
[TBL] [Abstract][Full Text] [Related]
30. Thalidomide for the treatment of cough in idiopathic pulmonary fibrosis: a randomized trial.
Horton MR; Santopietro V; Mathew L; Horton KM; Polito AJ; Liu MC; Danoff SK; Lechtzin N
Ann Intern Med; 2012 Sep; 157(6):398-406. PubMed ID: 22986377
[TBL] [Abstract][Full Text] [Related]
31. [Objectivation of the effect of antitussive agents using tussometry in patients with chronic cough].
Matthys H; Erhardt J; Rühle KH
Schweiz Med Wochenschr; 1985 Mar; 115(9):307-11. PubMed ID: 3885387
[TBL] [Abstract][Full Text] [Related]
32. Effect of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Women: A Randomized Clinical Trial.
Wang DS; Hu MT; Wang ZQ; Ren C; Qiu MZ; Luo HY; Jin Y; Fong WP; Wang SB; Peng JW; Zou QF; Tan Q; Wang FH; Li YH
JAMA Netw Open; 2021 Apr; 4(4):e215250. PubMed ID: 33835174
[TBL] [Abstract][Full Text] [Related]
33. A phase II study of hydrocodone for cough in advanced cancer.
Homsi J; Walsh D; Nelson KA; Sarhill N; Rybicki L; Legrand SB; Davis MP
Am J Hosp Palliat Care; 2002; 19(1):49-56. PubMed ID: 12171425
[TBL] [Abstract][Full Text] [Related]
34. Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled study.
Barth A; Hovhannisyan A; Jamalyan K; Narimanyan M
Phytomedicine; 2015 Dec; 22(13):1195-200. PubMed ID: 26598919
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of levodropropizine and dihydrocodeine on nonproductive cough in primary and metastatic lung cancer.
Luporini G; Barni S; Marchi E; Daffonchio L
Eur Respir J; 1998 Jul; 12(1):97-101. PubMed ID: 9701421
[TBL] [Abstract][Full Text] [Related]
36. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of aprepitant and dexamethasone after administration of chemotherapeutic agents and effects of plasma substance P concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients.
Takahashi T; Nakamura Y; Tsuya A; Murakami H; Endo M; Yamamoto N
Cancer Chemother Pharmacol; 2011 Sep; 68(3):653-9. PubMed ID: 21125277
[TBL] [Abstract][Full Text] [Related]
38. TRPV1 antagonists as potential antitussive agents.
McLeod RL; Correll CC; Jia Y; Anthes JC
Lung; 2008; 186 Suppl 1():S59-65. PubMed ID: 17926096
[TBL] [Abstract][Full Text] [Related]
39. Assessment of antitussive efficacy of dextromethorphan in smoking related cough: objective vs. subjective measures.
Ramsay J; Wright C; Thompson R; Hull D; Morice AH
Br J Clin Pharmacol; 2008 May; 65(5):737-41. PubMed ID: 18279476
[TBL] [Abstract][Full Text] [Related]
40. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
